Hangzhou Tigermed Consulting Co., Ltd

SZSE:300347 Stock Report

Market Cap: CN¥48.7b

Hangzhou Tigermed Consulting Balance Sheet Health

Financial Health criteria checks 5/6

Hangzhou Tigermed Consulting has a total shareholder equity of CN¥24.4B and total debt of CN¥3.7B, which brings its debt-to-equity ratio to 15.2%. Its total assets and total liabilities are CN¥30.3B and CN¥5.9B respectively. Hangzhou Tigermed Consulting's EBIT is CN¥1.3B making its interest coverage ratio -4.6. It has cash and short-term investments of CN¥2.0B.

Key information

15.2%

Debt to equity ratio

CN¥3.71b

Debt

Interest coverage ratio-4.6x
CashCN¥2.04b
EquityCN¥24.42b
Total liabilitiesCN¥5.86b
Total assetsCN¥30.28b

Recent financial health updates

Recent updates

Here's Why Hangzhou Tigermed Consulting (SZSE:300347) Can Manage Its Debt Responsibly

Dec 14
Here's Why Hangzhou Tigermed Consulting (SZSE:300347) Can Manage Its Debt Responsibly

Hangzhou Tigermed Consulting Co., Ltd's (SZSE:300347) Share Price Could Signal Some Risk

Aug 21
Hangzhou Tigermed Consulting Co., Ltd's (SZSE:300347) Share Price Could Signal Some Risk

Hangzhou Tigermed Consulting (SZSE:300347) Is Increasing Its Dividend To CN¥0.568

Jul 12
Hangzhou Tigermed Consulting (SZSE:300347) Is Increasing Its Dividend To CN¥0.568

Is Hangzhou Tigermed Consulting (SZSE:300347) A Risky Investment?

Jun 26
Is Hangzhou Tigermed Consulting (SZSE:300347) A Risky Investment?

An Intrinsic Calculation For Hangzhou Tigermed Consulting Co., Ltd (SZSE:300347) Suggests It's 35% Undervalued

Jun 07
An Intrinsic Calculation For Hangzhou Tigermed Consulting Co., Ltd (SZSE:300347) Suggests It's 35% Undervalued

Hangzhou Tigermed Consulting Co., Ltd Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Apr 28
Hangzhou Tigermed Consulting Co., Ltd Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Hangzhou Tigermed Consulting Co., Ltd (SZSE:300347) Stock Catapults 27% Though Its Price And Business Still Lag The Market

Apr 08
Hangzhou Tigermed Consulting Co., Ltd (SZSE:300347) Stock Catapults 27% Though Its Price And Business Still Lag The Market

Hangzhou Tigermed Consulting's (SZSE:300347) Profits Appear To Have Quality Issues

Apr 04
Hangzhou Tigermed Consulting's (SZSE:300347) Profits Appear To Have Quality Issues

Hangzhou Tigermed Consulting Co., Ltd Just Missed Earnings - But Analysts Have Updated Their Models

Apr 01
Hangzhou Tigermed Consulting Co., Ltd Just Missed Earnings - But Analysts Have Updated Their Models

Financial Position Analysis

Short Term Liabilities: 300347's short term assets (CN¥6.5B) exceed its short term liabilities (CN¥4.8B).

Long Term Liabilities: 300347's short term assets (CN¥6.5B) exceed its long term liabilities (CN¥1.1B).


Debt to Equity History and Analysis

Debt Level: 300347's net debt to equity ratio (6.8%) is considered satisfactory.

Reducing Debt: 300347's debt to equity ratio has increased from 11.5% to 15.2% over the past 5 years.

Debt Coverage: 300347's debt is well covered by operating cash flow (28.5%).

Interest Coverage: 300347 earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 08:01
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Hangzhou Tigermed Consulting Co., Ltd is covered by 39 analysts. 21 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Yang LuoBOCI Research Ltd.
Linda LuBOCI Research Ltd.
Bo LiBofA Global Research